Learn More
R&D Systems™ Human HB-EGF Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 259HE050
Description
The Recombinant Human HB-EGF Protein is derived from Sf 21 (baculovirus). The Recombinant Human HB-EGF Protein has been validated for the following applications: Bioactivity.Specifications
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. | |
9.7 kDa, 13 kDa, 14 kDa | |
50μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Recombinant |
1839 | |
HB-EGF | |
Spodoptera frugiperda,Sf 21 (baculovirus)-derived human HB-EGF protein Asp63-Leu148 | |
Unconjugated | |
97%, by SDS-PAGE with silver staining. |
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.